Production and Characterization of Polyclonal Antibodies Against Interferon Alpha in Mice
Abstract
Abstract Views: 210
The polyclonal antibodies are used extensively for research purposes in many areas of biology, such as immunoprecipitation, histochemistry, enzyme linked immunosorbent assays (ELISA), diagnosis of disease and western blots. Typically, an animal’s immune system will generate a large group of antibodies that recognize several epitopes of a particular antigen. Interferon alpha plays an important role in immune response activation and therefore is of interest in studies related to autoimmune diseases. In this paper the production of antibodies against interferon was studied in order to quantify interferon production to analyze interferon levels in autoimmune disorders in the future. For the antibody production, one month old laboratory grade mice were injected with interferon alpha in combination with a Freund’s complete adjuvant for a course of five weeks after which the antibodies were obtained in mouse serum. Confirmation of the production of anti-interferon alpha antibodies was carried out by the Elisa, immune dot blot and western blot analysis. An interferon alpha of approximately 20.5-21.5 KDa was detected in immunedot blot test. These antibodies may be produced in these mouse models commercially and could be used in future for treatment of autoimmune diseases by managing the interferon levels in the patients.
Keywords: ELISA, immune dot blot interferon, mice, polyclonal antibodies
Copyright(c) The Authors
Downloads
References
2. Benjamini E, Wan AM, Langton BC, Andria ML. Cell activation and immunogenicity. Dev Biol Stand. 1986;63:29-39. PMID: 3527819.
3. Bounds CE, Kwilas SA, Kuehne AI, Brannan JM, Bakken RR, Dye JM, et al. (2015) Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses. PLoS ONE 10(9): e0137786.
4. Bray M. The role of the Type I interferon response in the resistance of mice to filovirus infection. The Journal of general virology. 2001;82(Pt 6):1365–73.
5. Cooper HM, Patterson Y. Production of polyclonal antisera. Curr Protoc Immunol. 2008 Aug;Chapter 2:Unit 2.4.1-2.4.10. doi: 10.1002/0471142735.im0204s82. PMID: 18729062.
6. Cooper HM, Paterson Y. Production of polyclonal antisera. Curr Protoc Neurosci. 2009 Jul;Chapter 5:Unit 5.5. doi: 10.1002/0471142301.ns0505s48. PMID: 19575471.
7. Coligan JE, Tam JP, Shao J. Production of antipeptide antisera. Curr Protoc Neurosci. 2001 May;Chapter 5:Unit 5.6. doi: 10.1002/0471142301.ns0506s00. PMID: 18428505.
8. D. Overkamp, S. Mohammed-Ali, C. Cartledge & J. Landon (1988) Production of Polyclonal Antibodies in Ascitic Fluid of Mice: Technique and Applications, Journal of Immunoassay, 9:1, 51-68, DOI: 10.1080/01971528808053210
9. Harold F. Stills, Chapter 11 - Polyclonal Antibody Production, Editor(s): Mark A. Suckow, Karla A. Stevens, Ronald P. Wilson, In American College of Laboratory Animal Medicine, The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents, Academic Press, 2012, Pages 259-274, ISBN 9780123809209, doi: 10.1016/B978-0-12-380920-9.00011-0.
10. Kuroiwa, Y., Kasinathan, P., Sathiyaseelan, T. et al. Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol 27, 173–181 (2009). https://doi.org/10.1038/nbt.1521
11. Kuroiwa Y, Matsushita H, Sano A. Complex chromosome engineering for production of human antibodies in transgenic animals. Google Patents; 2014.
12. Matsushita H, Sano A, Wu H, Jiao JA, Kasinathan P, Sullivan EJ, et al. Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production. PloS one. 2014;9(3):e90383. pmid:24603704
13. Naimi WA, Gumpf JJ, Green RS, Izac JR, Zellner MP, Conrad DH, Marconi RT, Martin RK, Carlyon JA. Immunization against Anaplasma phagocytophilum Adhesin Binding Domains Confers Protection against Infection in the Mouse Model. Infect Immun. 2020 Sep 18;88(10):e00106-20. doi: 10.1128/IAI.00106-20. PMID: 32661123; PMCID: PMC7504939.
14. Olinger GG Jr, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(44):18030–5.
15. Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Science translational medicine. 2012;4(138):138ra81.
16. Sano A, Matsushita H, Wu H, Jiao JA, Kasinathan P, Sullivan EJ, et al. Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle. PloS one. 2013;8(10):e78119. pmid:24205120
17. Sissons JG, Oldstone MB. Antibody-mediated destruction of virus-infected cells. Adv Immunol. 1980;29:209-60. doi: 10.1016/s0065-2776(08)60045-0. PMID: 6251708; PMCID: PMC7173112.
18. Sissons JG, Oldstone MB. Killing of virus-infected cells: the role of antiviral antibody and complement in limiting virus infection. J Infect Dis. 1980 Sep;142(3):442-8. doi: 10.1093/infdis/142.3.442. PMID: 6255040.
Copyright (c) 2021 Mehreen Fatima, Fatima Khalid, Azra Quraishi
This work is licensed under a Creative Commons Attribution 4.0 International License.
BSR follows an open-access publishing policy and full text of all published articles is available free, immediately upon publication of an issue. The journal’s contents are published and distributed under the terms of the Creative Commons Attribution 4.0 International (CC-BY 4.0) license. Thus, the work submitted to the journal implies that it is original, unpublished work of the authors (neither published previously nor accepted/under consideration for publication elsewhere). On acceptance of a manuscript for publication, a corresponding author on the behalf of all co-authors of the manuscript will sign and submit a completed the Copyright and Author Consent Form.
